Advertisement

Advertisement

2024 JADPRO Live

Supportive Care

Managing Comorbidities in Oncology: Practical Strategies for Optimized Patient Care

Cancer care is increasingly complicated by the presence of comorbidities, which affect nearly two-thirds of patients at the time of diagnosis and can influence treatment decisions, participation in c...

Supportive Care
Pain Management

Balancing Pain Management and Addiction Risks in Oncology

Managing cancer pain in patients with substance use disorder presents a unique challenge for oncologists, requiring a balance between effective symptom management and mitigation of the risks of subst...

solid tumors

Cara Norelli, MS, AGNP-C, on Managing Dermatologic Side Effects in Patients With Cancer

Cara Norelli, MS, AGNP-C, of Memorial Sloan Kettering Cancer Center, discusses her presentation on dermatologic toxicities seen in patients with cancer from the JADPRO Live conference recently held in...

breast cancer

Kathryn Newlin, RN, MSN, ANP-BC, on Updates in HR-Positive, HER2-Negative Metastatic Breast Cancer

Kathryn Newlin, RN, MSN, ANP-BC, of Washington University in St. Louis, discusses her presentation on HR+ HER2- metastatic breast cancer from the JADPRO Live conference recently held in Grapevine, Tex...

solid tumors
hematologic malignancies

Justin Arnall, PharmD, BCOP, FCCP, on Complicating “Factors”: When Malignancy and Non-Malignant Hematology Collide

Justin Arnall, PharmD, BCOP, FCCP, of Atrium Health Specialty Pharmacy Service in Charlotte, North Carolina, discusses his JADPRO Live presentation on critical considerations when planning for cancer-...

Hematologic Malignancies

Understanding the Assessment and Treatment of High-Risk Myelofibrosis

At the 2024 JADPRO Live event, which is held annually for advanced practitioners in oncology, high-risk myelofibrosis was a featured topic. “The treatment landscape has developed so much that JADPRO...

Advertisement

Advertisement




Advertisement